eculizumab,iptacopan,Ravulizumab
Alexion Pharmaceuticals,novartis
['eculizumab']
late break abstracts #ash22 oral monotherapy with iptacopan, has superior efficacy to intravenous terminal complement inhibition with standard of care eculizumab or ravulizumab and favorable safety in patients with phn; study update: phase iii apply-ph. 
Mexican Hematologist. Oncohematology; hemostasis and thrombosis. Cruz Azul FC.